Cytidin-5′-diphosphocholine enhances the effect of part-time occlusion in amblyopia
- 67 Downloads
Cytidin-5′-diphosphocholine (CDP-choline) has been shown to improve visual acuity (VA), Contrast Sensitivity and Visual Evoked Responses at least temporarily, in amblyopic patients beyond the plastic period of the visual system. In this paper results are presented of a study conducted on forty-five patients with amblyopia in one eye, aged 5–9 years and followed for one year. Of them, 15 (Group A) were treated with CDP-choline (500 mg daily for 10 days every six months); 15 (Group B) were treated with CDP-choline plus one hour of occlusion daily; 15 (Group C) were treated with one hour of occlusion daily. The final VA values were statistically different from the initial ones, for all three groups. Eleven of the Group A patients showed an improvement in VA after the first treatment; a gradual deterioration took place in 6 patients at the end of the fourth month; VA further improved in 9 patients after the second treatment. At the end of the year, VA was higher than at the beginning in 12 of the 15 patients. Group B had an improvement of VA in 13 patients, starting 10 days from the beginning of treatment. This improvement continued throughout the observation period. Group C had an improvement after one month, which continued for 8 months, without deteriorating. In conclusion CDP-choline enhances the effect of part-time occlusion. CDP-choline could be employed also in younger patients. Longer observation periods are still needed and better means of administration have to be found.
Key wordsamblyopia cytidin-5′-diphosphocholine occlusion visual acuity
Unable to display preview. Download preview PDF.
- 1.Zappia V, Kennedy P, Nison BI, Galletti P. Novel Biochemical, Pharmacological and Clinical Aspects of Cytidinediphosphocoline, New York; Elsevier, 1985.Google Scholar
- 2.Campos EC, Schiavi C, Benedetti P, Bolzani R, Porciatti V. Effect of citicoline on visual acuity in amblyopia: preliminary results. Graefe's Arch Clin Exp Ophthalmol 1995: 233: 307–312.Google Scholar
- 3.Porciatti V, Benedetti P, Schiavi C, Domenici L, Campos EC. Citicoline treatment improves contrast sensitivity and VEPs of strabismic amblyopes. Invest Ophthalmol & Visual Sci 1994; 35/4: 1994.Google Scholar
- 4.Noorden GK von. Binocular Vision and Ocular Motility. Theory and Management of Strabismus. 5th Edition. St. Louis; CV Mosby, 1995.Google Scholar
- 6.Domenici L, Trimarchi C, Piccolino M, Fiorentini A, Maffei L. Dopaminergic drugs improve human visual contrast sensitivity. Human Neurobiol 1985; 4: 195–197.Google Scholar
- 7.Gottlob I, Charlier J, Reinecke RD. Visual acuity and scotomas after one week of levodopa administration in human amblyopia. Invest Ophthalmol & Visual Sci 1992; 33: 2722–2728.Google Scholar
- 8.Gottlob I, Stangler-Zuschrott E. Effect of levodopa on contrast sensitivity and scotomas in human amblyopia. Invest Ophthalmol & Visual Sci 1990; 31: 766–780.Google Scholar
- 10.Leguire LE, Rogers GL, Bremer DL, Walson PD, McGregor ML. Levodopa/carbidopa for childhood amblyopia. Invest Ophthalmol & Visual Sci 1993; 34: 3090–3095.Google Scholar
- 12.Leguire LE, Walson PD, Rogers Gl, Bremer DL, McGregor ML: Levodopa/Carbidopa treatment for amblyopia in older children. J Ped Ophthalmol Strab 1995; 32: 143–151.Google Scholar